BRTX · Registration Statement (Form S-1) · Filed November 18, 2025

Biorestorative Therapies Inc — S-1 exhibit

ex10-49.htm

Biorestorative Therapies Inc on Boardroom Alpha

Exhibit 10.49

October 15, 2025

Auctus Fund, LLC

545 Boylston Street, 2^nd Floor

Boston, Massachusetts, 02116

Gentlemen:

Reference is made to the Common Stock Purchase Warrant, dated October 8, 2025, issued by BioRestorative Therapies, Inc. (the “Company”) to Auctus Fund, LLC (“Auctus”) for the purchase of up to 187,500 shares of common stock of the Company (the “Warrant”).

The parties understand that all other warrants and preferred stock of the Company held by Auctus provide for a 9.99% beneficial ownership limitation and that the Warrant currently provides for a 4.99% beneficial ownership limitation. The parties agree that it was intended that the Warrant provide for a 9.99% beneficial ownership limitation. Accordingly, the parties agree that the next to last sentence of Section 1(c) of the Warrant is amended to read as follows:

“The “Beneficial Ownership Limitation” shall be 9.99% of the number of shares of the Common Stock outstanding at the time of the respective calculation hereunder.”

Except as modified herein, the Warrant shall continue in full force and effect in accordance with its terms.

This letter may be executed in counterparts, each of which shall be deemed an original, but all of which taken together shall constitute one and the same instrument.

This letter shall be governed by, and construed in accordance with, the laws of the State of New York, excluding choice of law principles thereof.

	Very truly yours,

	BIORESTORATIVE THERAPIES, INC.

	By:
		Lance Alstodt
		Chief Executive Officer

Agreed:

AUCTUS FUND, LLC

By:
	Lou Posner
	Managing Director

Disclaimer

The opinions and information contained herein have been obtained or derived from sources believed to be reliable, but Boardroom Alpha cannot guarantee its accuracy and completeness, and that of the opinions based thereon.

This report contains opinions and is provided for informational purposes only – it does not constitute investment, legal or tax advice. You should not rely solely upon the research herein for purposes of transacting securities or other investments, and you are encouraged to conduct your own research and due diligence, and to seek the advice of a qualified securities professional before you make any investment.

None of the information contained in this report constitutes, or is intended to constitute a recommendation by Boardroom Alpha of any particular security or trading strategy or a determination by Boardroom Alpha that any security or trading strategy is suitable for any specific person. To the extent any of the information contained herein may be deemed to be investment advice, such information is impersonal and not tailored to the investment needs of any specific person.

No representation or warranty, expressed or implied, is made on behalf of Boardroom Alpha as to the accuracy or completeness of the information contained herein. Boardroom Alpha does not accept any liability for any direct, indirect or consequential loss or damage suffered by any person as a result of relying on all or any part of this research and any liability is expressly disclaimed.

Full disclaimer